The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma

被引:52
作者
Kaur, Harpreet [1 ,2 ,3 ]
Ali, Sabeen Zulfiqar [1 ,2 ]
Huey, Lauren [1 ,2 ]
Hutt-Cabezas, Marianne [1 ,2 ,3 ]
Taylor, Isabella [3 ]
Mao, Xing-gang [1 ,2 ]
Weingart, Melanie [1 ,2 ]
Chu, Qian [1 ,2 ]
Rodriguez, Fausto J. [1 ,2 ]
Eberhart, Charles G. [1 ,2 ]
Raabe, Eric H. [1 ,2 ,3 ]
机构
[1] Johns Hopkins Univ, Div Neuropathol, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA
[3] Johns Hopkins Univ, Bloomberg Childrens Hosp, Div Pediat Oncol, Room 11379,1800 Orleans St, Baltimore, MD 21287 USA
关键词
Glioma; Motility; Clonogenicity; GSC; HMGI-C; MOBILITY GROUP A2; AT-HOOK; 2; CHROMATIN-STRUCTURE; TARGETING HMGA2; CELL-MIGRATION; GASTRIC-CANCER; PROTEIN HMGA2; BRAIN-TUMOR; LET-7; GENE;
D O I
10.1016/j.canlet.2016.04.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Glioblastoma (GBM) contains a population of stem-like cells that promote tumor invasion and resistance to therapy. Identifying and targeting stem cell factors in GBM may lead to the development of more effective therapies. High Mobility Group AT-hook 2 (HMGA2) is a transcriptional modulator that mediates motility and self-renewal in normal and cancer stem cells. We identified increased expression of HMGA2 in the majority of primary human GBM tumors and cell lines compared to normal brain. Additionally, HMGA2 expression was increased in CD133+ GBM neurosphere cells compared to CD133- cells. Targeting HMGA2 with lentiviral short hairpin RNA (shRNA) led to decreased GBM stemness, invasion, and tumorigenicity. Ectopic expression of HMGA2 in GBM cell lines promoted stemness, invasion, and tumorigenicity. Our data suggests that targeting HMGA2 in GBM may be therapeutically beneficial. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:55 / 64
页数:10
相关论文
共 73 条
[1]   Glioblastoma, a Brief Review of History, Molecular Genetics, Animal Models and Novel Therapeutic Strategies [J].
Agnihotri, Sameer ;
Burrell, Kelly E. ;
Wolf, Amparo ;
Jalali, Sharzhad ;
Hawkins, Cynthia ;
Rutka, James T. ;
Zadeh, Gelareh .
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2013, 61 (01) :25-41
[2]   High mobility Group I-C protein in astrocytoma and glioblastoma [J].
Akai, T ;
Ueda, Y ;
Sasagawa, Y ;
Hamada, T ;
Date, T ;
Katsuda, S ;
Iizuka, H ;
Okada, Y ;
Chada, K .
PATHOLOGY RESEARCH AND PRACTICE, 2004, 200 (09) :619-624
[3]   Glioblastoma Multiforme Overview of Current Treatment and Future Perspectives [J].
Anton, Kevin ;
Baehring, Joachim M. ;
Mayer, Tina .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2012, 26 (04) :825-+
[4]   Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma [J].
Bar, Eli E. ;
Chaudhry, Aneeka ;
Lin, Alex ;
Fan, Xing ;
Schreck, Karisa ;
Matsui, William ;
Piccirillo, Sara ;
Vescovi, Angelo L. ;
DiMeco, Francesco ;
Olivi, Alessandro ;
Eberharta, Charles G. .
STEM CELLS, 2007, 25 (10) :2524-2533
[5]   Hypoxia Increases the Expression of Stem-Cell Markers and Promotes Clonogenicity in Glioblastoma Neurospheres [J].
Bar, Eli E. ;
Lin, Alex ;
Mahairaki, Vasiliki ;
Matsui, William ;
Eberhart, Charles G. .
AMERICAN JOURNAL OF PATHOLOGY, 2010, 177 (03) :1491-1502
[6]   Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer [J].
Cai, Junyan ;
Shen, Guangyu ;
Liu, Su ;
Meng, Qingbing .
TUMOR BIOLOGY, 2016, 37 (01) :699-707
[7]   Low-molecular-mass secretome profiling identifies HMGA2 and MIF as prognostic biomarkers for oral cavity squamous cell carcinoma [J].
Chang, Kai-Ping ;
Lin, Shih-Jie ;
Liu, Shiau-Chin ;
Yi, Jui-Shan ;
Chien, Kun-Yi ;
Chi, Lang-Ming ;
Kao, Huang-Kai ;
Liang, Ying ;
Lin, Yu-Tsun ;
Chang, Yu-Sun ;
Yu, Jau-Song .
SCIENTIFIC REPORTS, 2015, 5
[8]   miR-485-5p inhibits bladder cancer metastasis by targeting HMGA2 [J].
Chen, Zhijun ;
Li, Qingwen ;
Wang, Sheng ;
Zhang, Jiajun .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 (04) :1136-1142
[9]   HMGA1 and HMGA2 protein expression in mouse spermatogenesis [J].
Chieffi, P ;
Battista, S ;
Barchi, M ;
Di Agostino, S ;
Pierantoni, GM ;
Fedele, M ;
Chiariotti, L ;
Tramontano, D ;
Fusco, A .
ONCOGENE, 2002, 21 (22) :3644-3650
[10]   Prolonged Inhibition of Glioblastoma Xenograft Initiation and Clonogenic Growth following In Vivo Notch Blockade [J].
Chu, Qian ;
Orr, Brent A. ;
Semenkow, Samantha ;
Bar, Eli E. ;
Eberhart, Charles G. .
CLINICAL CANCER RESEARCH, 2013, 19 (12) :3224-3233